Thermo Fisher Scientific | TMO - Ebitda





Ebitda Veränderung Datum
Abbott USD 2.43B 844M 2026-03
Agilent USD 456M 84M 2025-12
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Bio Techne USD 116.71M 13.29M 2026-03
Bio-Rad Laboratories USD -636.6M 1.62B 2026-03
Boston Scientific USD 1.63B 27M 2026-06
Bruker USD 143.2M 33.2M 2026-06
Charles River Laboratories USD 272.95M 43.14M 2026-06
Danaher USD 1.84B 81M 2026-06
Dentsply International USD 190M 61M 2026-06
Edwards Lifesciences USD 555.6M 485.5M 2026-03
General Electric Aerospace USD 3.06B 219M 2026-06
Henry Schein USD 288M 1000K 2026-06
Illumina USD 330M 80M 2026-06
Intuitive Surgical USD 1.06B 29.9M 2026-03
IQVIA Holdings USD 994M 62M 2026-06
Laboratory Of America USD 767.7M 162.1M 2026-06
Medtronic USD 2.81B 119M 2026-03
Mettler Toledo International USD 322.64M 43.66M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
Olympus JPY 46.26B 2.85B 2026-06
OraSure Technologies USD -17.7M 4.06M 2025-12
Quest Diagnostics USD 648M 91M 2026-06
Repligen USD 43.77M 3.76M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Stryker USD 1.93B 357M 2026-06
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Veracyte USD 43.96M 1.16M 2026-06
Waters USD 712M 545M 2026-06
Zimmer Biomet Holdings USD 830.5M 190.4M 2026-06